Get 20% Free Customization In This Report

Buy this report from - $3456

Artificial Pancreas Devices System Market by Type (CTR [control to range] systems and CTT [control to target]), and by End-User (Hospitals, Medical Centers, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Medical Devices & Supplies	LI_183874	Pages: NA	Jun 2018 \| 542 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Artificial organs are human-made bio-artificial organs, which are implanted into the body to replace or support natural organs. Artificial organs include artificial heart, kidney, pancreas, and cochlear implants. They are made of biocompatible materials such as polymers, biologics, ceramics, and metals. Artificial pancreas is implanted with different technologies such as sensors, biomaterials, and innovative delivery systems. Moreover, artificial pancreas perform the function same as the natural pancreas and helps the patient live a quality life.

Factors such as the rising prevalence of type-1 diabetes, increasing demand for insulin self-administration, and rising geriatric population drive the market growth. In addition, increase in the awareness of the population and collaboration of FDA with private institutes fuel the market growth. However, lack of skilled professionals in underdeveloped regions such as Africa and South America are expected to hinder the growth of the market. R&D in the field of medical equipment is anticipated to create new opportunities during the forecast period.

The artificial pancreas devices market is segmented on the basis of type, end-user, and geography. By type the market is segmented into CTR (control to range) and CTT (control to target). By end-user the market is categorized into hospitals, medical centers, and others. Geographically, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

The study provides an in-depth analysis of the artificial pancreas devices system market, with current trends and future estimations to elucidate investment pockets.
Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
The report offers a quantitative analysis to assist stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of different segments determines various products available in the market.
Key players have been profiled and their strategies thoroughly analyzed to predict the competitive market outlook.

Artificial Pancreas Devices System Market Key Segments:

By Type

CTR (Control to Range) Systems
CTT (Control to Target) Systems

By End-User

Hospital
Medical Centres
Others

By Geography

North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
LAMEA
- Latin America
- The Middle East
- Africa

List of players profiled in the report

Medtronic Plc
Johnson & Johnson
Insulet Corp
Tandem Diabetes Care
F. Hoffmann-La Roche Ltd
Beta Bionics
Bigfoot Biomedical, Inc.
Inreda Diabetic B.V.
Dexcom, Inc.
Cellnovo

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 ARTIFICIAL PANCREAS DEVICES SYSTEM MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. CTR (CONTROL TO RANGE) SYSTEMS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. CTT (CONTROL TO TARGET) SYSTEMS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

Chapter: 5 ARTIFICIAL PANCREAS DEVICES SYSTEM MARKET, BY END-USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS

5.2.1. Market size and forecast

5.3. MEDICAL CENTRES

5.3.1. Market size and forecast

5.4. OTHERS

5.4.1. Market size and forecast

Chapter: 6 ARTIFICIAL PANCREAS DEVICES SYSTEM MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Artificial Pancreas Devices System Market by Type
6.2.5. North America Artificial Pancreas Devices System Market by End-User

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. UK market size and forecast
6.3.3.2. Germany market size and forecast
6.3.3.3. France market size and forecast
6.3.3.4. Spain market size and forecast
6.3.3.5. Italy market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe Artificial Pancreas Devices System Market by Type
6.3.5. Europe Artificial Pancreas Devices System Market by End-User

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. China market size and forecast
6.4.3.2. Japan market size and forecast
6.4.3.3. India market size and forecast
6.4.3.4. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Artificial Pancreas Devices System Market by Type
6.4.5. Asia-Pacific Artificial Pancreas Devices System Market by End-User

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Latin America market size and forecast
6.5.3.2. The Middle East market size and forecast
6.5.3.3. Africa market size and forecast

6.5.4. LAMEA Artificial Pancreas Devices System Market by Type
6.5.5. LAMEA Artificial Pancreas Devices System Market by End-User

Chapter: 7 COMPANY PROFILES

7.1. MEDTRONIC PLC

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. JOHNSON & JOHNSON

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. INSULET CORP

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. TANDEM DIABETES CARE

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. F. HOFFMANN-LA ROCHE LTD

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. BETA BIONICS

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. BIGFOOT BIOMEDICAL, INC.

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. INREDA DIABETIC B.V.

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. DEXCOM, INC.

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. CELLNOVO

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.